RETRACTION: miR-338-3p suppresses tumor growth of ovarian epithelial carcinoma by targeting Runx2 (Retraction of Vol 46, Pg 2277, 2015)

被引：0
|
作者：
Wen, Chunyan
Liu, Xiaojun
Ma, Hongxi
Zhang, Wenjie
Li, Haifeng
机构：
来源：
INTERNATIONAL JOURNAL OF ONCOLOGY | 2021年 / 59卷 / 02期
关键词：
D O I：
10.3892/ijo.2021.5237
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting FGFR2/FRS2
    Shan, Xia
    Zhang, Cheng
    Li, Chunyu
    Fan, Xingchen
    Song, Guoxin
    Zhu, Jingfeng
    Cao, Risheng
    Zhang, Xiuwei
    Zhu, Wei
    CANCER PATHOGENESIS AND THERAPY, 2023, 1 (02): : 87 - 97
  • [42] RETRACTION: Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer (Retraction of Vol 466, Pg 103, 2020)
    Guo, Ying
    Liang, Fei
    Zhao, Fuli
    Zhao, Jian
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2022, 477 (11) : 2687 - 2687
  • [43] RETRACTION: MiR-490-5p Suppresses Cell Proliferation and Invasion by Targeting BUB1 in Hepatocellular Carcinoma Cells (Retraction of Vol 100, Pg 269, 2017)
    Xu, Bin
    Xu, Tangpeng
    Liu, Huali
    Min, Qian
    Wang, Shidong
    Song, Qibin
    PHARMACOLOGY, 2023, 108 (05) : 495 - 495
  • [44] RETRACTION: LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis (Retraction of Vol 125, art no 110039, 2020)
    Wen, Dacheng
    Li, Songhe
    Jiang, Weidong
    Zhao, Shutao
    Liu, Jingjing
    Zhu, Jiaming
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [45] Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2
    He, Juanjuan
    Wang, Jing
    Li, Songchao
    Li, Teng
    Chen, Kunlun
    Zhang, Shaojin
    CANCER SCIENCE, 2020, 111 (10) : 3550 - 3563
  • [46] RETRACTION: MiR-132 inhibits cell proliferation, invasion and migration of hepatocellular carcinoma by targeting PIK3R3 (Retraction of Vol 47, Pg 1585, 2015)
    Liu, Kai
    Li, Xingliang
    Cao, Yuchen
    Ge, Yuanyuan
    Wang, Jianmeng
    Shi, Bo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 59 (02)
  • [47] RETRACTION: MiR-212-5p Suppresses the Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer by Targeting Prrx2 (Retraction of Vol 44, Pg 1785, 2017)
    Lv, Zhi-Dong
    Yang, Dong-Xia
    Liu, Xiang-Ping
    Jin, Li-Ying
    Wang, Xin-Gang
    Yang, Zhao-Chuan
    Liu, Dong
    Zhao, Jiao-Jiao
    Kong, Bin
    Li, Fu-Nian
    Wang, Hai-Bo
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2023, 57 (03) : 199 - 199
  • [48] RETRACTION: miR-663 attenuates tumor growth and invasiveness by targeting eEF1A2 in pancreatic cancer (Retraction of Vol 14, art no 37, 2015)
    Zang, Wenqiao
    Wang, Yuanyuan
    Wang, Tao
    Du, Yuwen
    Chen, Xiaonan
    Li, Min
    Zhao, Guoqiang
    MOLECULAR CANCER, 2019, 18 (1)
  • [49] RETRACTION: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1 (Retraction of Vol 392, Pg 1477, 2019)
    Li, Qian
    Jiang, Chuanwu
    Wang, Yan
    Wei, Minghua
    Zheng, Huijin
    Xu, Yanqi
    Xu, Xuegang
    Jia, Fengyu
    Liu, Kai
    Sun, Gang
    Zang, Jianhua
    Mo, Ping
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (03) : 575 - 575
  • [50] RETRACTION: MiR-125a-3p Suppresses the Growth and Progression of Papillary Thyroid Carcinoma Cell by Targeting MMP11
    Song, M.
    Wang, N.
    Li, Z.
    Zhang, Y.
    Zheng, Y.
    Yi, P.
    Chen, J.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2025, 126 (04)
12345